S0404 Improved Histopathologic Features in Patients With Eosinophilic Esophagitis: Results and Analyses From a Phase 3, Randomized, Placebo-Controlled Trial of Budesonide Oral Suspension

Margaret H. Collins; Ikuo Hirano; David A. Katzka; Vincent A. Mukkada; Gary W. Falk; James E. Williams; Nirav K. Desai; Lan Lan; Evan S. Dellon

doi:10.14309/01.ajg.0000703664.24718.78

S0404 Improved Histopathologic Features in Patients With Eosinophilic Esophagitis: Results and Analyses From a Phase 3, Randomized, Placebo-Controlled Trial of Budesonide Oral Suspension

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000703664.24718.78 ◽

2020 ◽

Vol 115 (1) ◽

pp. S200-S201

Author(s):

Margaret H. Collins ◽

Ikuo Hirano ◽

David A. Katzka ◽

Vincent A. Mukkada ◽

Gary W. Falk ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Histopathologic Features

Download Full-text

Mo1183 PREDICTORS OF RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION

Gastroenterology ◽

10.1016/s0016-5085(20)32723-2 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-817-S-818

Author(s):

Ikuo Hirano ◽

David A. Katzka ◽

Margaret H. Collins ◽

Vincent A. Mukkada ◽

Benjamin D. Gold ◽

...

Keyword(s):

Corticosteroid Therapy ◽

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Predictors Of Response

Download Full-text

PGI36 ESTIMATION OF THE MINIMAL IMPORTANT DIFFERENCES IN EUROQOL-5 DIMENSIONS (EQ-5D) FOR PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION

Value in Health ◽

10.1016/j.jval.2020.04.390 ◽

2020 ◽

Vol 23 ◽

pp. S149

Author(s):

B. Goodwin ◽

J. Williams ◽

N.K. Desai ◽

L. Lan

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Minimal Important Differences

Download Full-text

350 Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled Trial

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000590932.88962.0b ◽

2019 ◽

Vol 114 (1) ◽

pp. S205-S206 ◽

Cited By ~ 5

Author(s):

Ikuo Hirano ◽

Margaret H. Collins ◽

David A. Katzka ◽

Vincent A. Mukkada ◽

Gary W. Falk ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Adolescents And Adults

Download Full-text

227 BUDESONIDE ORAL SUSPENSION (BOS) IMPROVES ENDOSCOPIC ACTIVITY IN ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS AND CORRELATION ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Gastroenterology ◽

10.1016/s0016-5085(20)30788-5 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-42-S-43

Author(s):

Ikuo Hirano ◽

Margaret H. Collins ◽

David A. Katzka ◽

Vincent A. Mukkada ◽

Gary W. Falk ◽

...

Keyword(s):

Correlation Analysis ◽

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Adolescents And Adults

Download Full-text

Budesonide Oral Suspension Improves Histologic Features In Patients With Eosinophilic Esophagitis: Results From A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2019.12.341 ◽

2020 ◽

Vol 145 (2) ◽

pp. AB166

Author(s):

Margaret Collins ◽

Ikuo Hirano ◽

David Katzka ◽

Antonella Cianferoni ◽

James Williams ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

S0435 Determination of the Eosinophilic Esophagitis Endoscopic Reference Score Associated With Histologic Response to Therapy: Analysis From a Phase 3 Placebo-Controlled Trial of Budesonide Oral Suspension

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000703788.60508.8e ◽

2020 ◽

Vol 115 (1) ◽

pp. S217-S218

Author(s):

Ikuo Hirano ◽

Margaret H. Collins ◽

David A. Katzka ◽

Vincent A. Mukkada ◽

Gary W. Falk ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Response To Therapy ◽

Oral Suspension ◽

Histologic Response ◽

Phase 3

Download Full-text

PGI1 ESTIMATION OF THE MINIMAL IMPORTANT DIFFERENCES IN EOSINOPHILIC ESOPHAGITIS QUALITY OF LIFE (EOE-QOL): ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION

Value in Health ◽

10.1016/j.jval.2020.04.361 ◽

2020 ◽

Vol 23 ◽

pp. S143

Author(s):

B. Goodwin ◽

J. Williams ◽

N.K. Desai ◽

L. Lan

Keyword(s):

Quality Of Life ◽

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Oral Suspension ◽

Phase 3 ◽

Minimal Important Differences

Download Full-text

Efficacy And Safety Of Budesonide Oral Suspension In A Pediatric Population: Pooled Data From A Phase 2 And Phase 3 Trial In Patients With Eosinophilic Esophagitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.12.348 ◽

2021 ◽

Vol 147 (2) ◽

pp. AB91

Author(s):

Sandeep Gupta ◽

Vincent Mukkada ◽

Evan Dellon ◽

Benjamin Gold ◽

Margaret Collins ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Pediatric Population ◽

Oral Suspension ◽

Phase 2 ◽

Efficacy And Safety ◽

Phase 3 ◽

Pooled Data

Download Full-text

Clinical Features at Baseline are Not Clearly Associated with Symptomatic Placebo Response in Adolescents and Adults with Eosinophilic Esophagitis During a Placebo Run-in Period of a Double-Blind, Randomized, Controlled Trial of Budesonide Oral Suspension

Gastroenterology ◽

10.1016/s0016-5085(17)32941-4 ◽

2017 ◽

Vol 152 (5) ◽

pp. S854 ◽

Cited By ~ 2

Author(s):

Ikuo Hirano ◽

James Williams ◽

Margaret H. Collins ◽

Evan S. Dellon ◽

Sharif Uddin ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Clinical Features ◽

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Placebo Response ◽

Oral Suspension ◽

Double Blind ◽

Randomized Controlled ◽

Adolescents And Adults

Download Full-text

Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2021.06.033 ◽

2021 ◽

Author(s):

Ikuo Hirano ◽

Margaret H. Collins ◽

David A. Katzka ◽

Vincent A. Mukkada ◽

Gary W. Falk ◽

...

Keyword(s):

Eosinophilic Esophagitis ◽

Oral Suspension ◽

Phase 3

Download Full-text